Melanoma Clinical Trial
A Post-marketing Study on the Safety of Abatacept Treatment in Denmark Using the Danish Database
Summary
The purpose of this study is to expand on the ongoing post-marketing monitoring of abatacept to include all participants with rheumatoid arthritis (RA) and psoriatic arthritis (PsA) treated with abatacept captured in Danish Database for Biologic Therapies (DANBIO).
View Eligibility Criteria
Eligibility Criteria
Inclusion Criteria:
Diagnosis of rheumatoid arthritis (RA) or psoriatic arthritis (PsA)
Receiving treatment with abatacept
Receiving treatment with non-targeted DMARD
Receiving treatment with targeted DMARD
Exclusion Criteria:
-Not applicable
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
Submit
There is 1 Location for this study
See Locations Near You
Local Institution
Princeton New Jersey, 08540, United States
Princeton New Jersey, 08540, United States
How clear is this clinincal trial information?